Skip to content

OÜ Pharmandia

Registry code (registrikood) 14213834Private limited company (Osaühing)VAT EE101956697Activity (EMTAK 47731): Ravimite jaemüükActive

Tallinn, Harju County · Financial data: annual reports up to 2025; tax data up to 2026 Q3

Revenue (2025)
€3.1M
▲ 2.0% vs 2024
Profit before tax (2025)
€89k
Employees, FTE (2025)
4
State taxes paid, last 4 quarters
€26k

Revenue, profit and employees, 2019–2025

€2.4M2019€2.6M2020€2.6M2021€2.8M2022€3.1M2023€3.0M2024€3.1M2025
YearRevenue (müügitulu)Operating profit (ärikasum)Net profitEquity (omakapital)Employees, FTE
2019€2,386,847-€272,859-€315,198-€533,35320
2020€2,574,755-€84,150-€133,923-€623,09118
2021€2,589,684€60,824€11,184-€611,9082
2022€2,778,271-€47,718-€100,002-€711,9103
2023€3,052,501€12,364-€70,001-€1,293,7004
2024€3,030,463€104,612€84,241-€1,209,4594
2025€3,090,545€106,629€89,294-€1,120,1654

Balance sheet summary

YearCashTotal assetsCurrent liabilitiesNon-current liabilitiesEquity
2019€63,048€1,213,159€1,746,512—-€533,353
2020€42,329€1,472,010€2,095,101—-€623,091
2021€55,330€1,373,083€1,984,991—-€611,908
2022€149,930€1,344,044€2,055,954—-€711,910
2023€63,783€595,401€1,889,101—-€1,293,700
2024€72,037€575,918€1,785,377—-€1,209,459
2025€76,725€567,945€1,688,110—-€1,120,165

Calculated ratios

Net profit margin = net profit ÷ revenue. Equity ratio = equity ÷ total assets. Seedata sources & methodology for how each figure is derived.

Quarterly tax and turnover data (EMTA)

QuarterState taxes paidWage taxesTurnoverEmployees
2022 Q1€0€6,434€682,9445
2022 Q2€4,375€6,432€674,9505
2022 Q3€12,614€13,484€637,9748
2022 Q4€6,478€13,115€747,5088
2023 Q1€8,861€13,760€702,0067
2023 Q2€8,940€11,908€696,4817
2023 Q3€8,056€10,198€666,3937
2023 Q4€15,615€15,799€972,8817
2024 Q1€9,853€14,026€753,5187
2024 Q2€4,644€14,270€741,9447
2024 Q3€11,768€16,329€711,5159
2024 Q4€13,199€16,598€810,45812
2025 Q1€22,713€15,780€773,85012
2025 Q2€9,911€13,402€740,67112
2025 Q3€10,717€14,433€692,43510
2025 Q4€11,381€13,412€851,2449
2026 Q1€4,403€12,778€847,9389
2026 Q2€3,354€13,044€807,44612
2026 Q3€7,294€12,386€835,61314

Source: EMTA quarterly published data, as of 10 October 2026. Covers state taxes and wage taxes actually paid and turnover and employee counts as declared by the company, not the annual report figures above.

About this data

In the 2025 financial year (period 1 January 2025–31 December 2025), OÜ Pharmandia reported revenue of €3,090,545.

The company closed the 2025 financial year with a net profit of €89,294.

Revenue increased by 2.0% from €3,030,463 in 2024 to €3,090,545 in 2025.

Revenue grew at a compound annual rate of 4.4% between 2019 and 2025.

Equity accounted for -197.2% of total assets of €567,945 at the end of the 2025 reporting period.

With 4 full-time-equivalent employees in 2025, revenue per employee was €772,636.

Across the 4 most recent quarters declared to EMTA, up to Q3 2026, OÜ Pharmandia reported €3,342,241 in turnover.

EMTA recorded 14 employees for the quarter ending Q3 2026, compared with 4 full-time-equivalent employees in the 2025 annual report.

Browse

Source

Source: Estonian e-Business Register open data (Centre of Registers and Information Systems, RIK), licence CC BY-SA 4.0, modified; Estonian Tax and Customs Board (EMTA) quarterly data. Downloaded 2026-11-16. This is not an official register extract — see ariregister.rik.ee.

Company data on this site is available under CC BY-SA 4.0.

To request a correction or the removal of this page, use the contact form. Removal requests are handled within 30 days, no justification required.